Nir Paran

4.8k citations

58 papers · 2.0k indexed · 3 hit papers · h-index 24

Impact in

Virology top 1%
- Poxvirus research and outbreaks
Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology

Papers in ⓘ

Virology 27
- Poxvirus research and outbreaks 24
Infectious Diseases 23
- SARS-CoV-2 and COVID-19 Research 17
- COVID-19 Clinical Research Studies 6

Co-authors: Sharon Melamed (28 shared papers)Tomer Israely (32 shared papers)Hadas Tamir (17 shared papers)Yfat Yahalom-Ronen (18 shared papers)Ofir Israeli (16 shared papers)Hagit Achdout (17 shared papers)Shay Weiss (14 shared papers)Yosef Shaul (6 shared papers)
Journals: Viruses (5 papers)The Journal of Infectious Diseases (4 papers)Scientific Reports (3 papers)Vaccine (3 papers)Nature Communications (3 papers)
Partner nations: Israel United States Japan

In The Last Decade

Nir Paran

57 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis 2021 · 160 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Nature
2020 Nature
2019 Emerging infectious diseases

Peers

Countries citing papers authored by Nir Paran

Since Specialization

Citations

This map shows the geographic impact of Nir Paran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nir Paran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nir Paran more than expected).

Fields of papers citing papers by Nir Paran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nir Paran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nir Paran. The network helps show where Nir Paran may publish in the future.

Co-authors

The 25 scholars most cited alongside Nir Paran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nir Paran Line = papers co-authored together Nir Paran links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The coding capacity of SARS-CoV-2 Nature ·Yaara Finkel, Orel Mizrahi, Aharon Nachshon, Shira Weingarten-Gabbay, David Morgenstern, Yfat Yahalom-Ronen, Hadas Tamir, Hagit Achdout, Dana Stein, Ofir Israeli, Adi Beth-Din, Sharon Melamed, Shay Weiss, Tomer Israely, Nir Paran, Michal Schwartz, Noam Stern‐Ginossar Hit paper breakdown →	2020	382
2	Diagnosis of Imported Monkeypox, Israel, 2018 Emerging infectious diseases ·Noam Erez, Hagit Achdout, Elad Milrot, Yuval Schwartz, Yonit Wiener‐Well, Nir Paran, Boaz Politi, Hadas Tamir, Tomer Israely, Shay Weiss, Adi Beth-Din, Ohad Shifman, Ofir Israeli, Shmuel Yitzhaki, Shmuel C. Shapira, Sharon Melamed, Eli Schwartz Hit paper breakdown →	2019	302
3	SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis Nature ·Yaara Finkel, Avi Gluck, Aharon Nachshon, Roni Winkler, Tal Fisher, Batsheva Rozman, Orel Mizrahi, Yoav Lubelsky, B. M. Zuckerman, Boris Slobodin, Yfat Yahalom-Ronen, Hadas Tamir, Igor Ulitsky, Tomer Israely, Nir Paran, Michal Schwartz, Noam Stern‐Ginossar Hit paper breakdown →	2021	160
4	PGC-1α controls hepatitis B virus through nutritional signals Proceedings of the National Academy of Sciences ·Amir Shlomai, Nir Paran, Yosef Shaul	2006	97
5	Detection of Zika virus RNA in whole blood of imported Zika virus disease cases up to 2 months after symptom onset, Israel, December 2015 to April 2016 Eurosurveillance ·Yaniv Lustig, Ella Mendelson, Nir Paran, Sharon Melamed, Eli Schwartz	2016	90
6	Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles ACS Nano ·Uri Elia, Srinivas Ramishetti, Ronit Rosenfeld, Niels Dammes, Erez Bar‐Haim, Gonna Somu Naidu, Efi Makdasi, Yfat Yahalom-Ronen, Hadas Tamir, Nir Paran, Ofer Cohen, Dan Peer	2021	84
7	HBV infection of cell culture: evidence for multivalent and cooperative attachment The EMBO Journal ·Nir Paran	2001	75
8	Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity Nature Communications ·Hagit Achdout, Einat B. Vitner, Boaz Politi, Sharon Melamed, Yfat Yahalom-Ronen, Hadas Tamir, Noam Erez, Roy Avraham, Shay Weiss, Lilach Cherry, Erez Bar‐Haim, Efi Makdasi, David Gur, Moshe Aftalion, Theodor Chitlaru, Yaron Vagima, Nir Paran, Tomer Israely	2021	50
9	Postexposure Immunization with Modified Vaccinia Virus Ankara or Conventional Lister Vaccine Provides Solid Protection in a Murine Model of Human Smallpox The Journal of Infectious Diseases ·Nir Paran, Yasemin Suezer, Shlomo Lustig, Tomer Israely, Astrid Schwantes, Sharon Melamed, L. J. Katz, Thomas G. Preuß, Kay-Martin Hanschmann, Ulrich Kalinke, Noam Erez, Reuven Levin, Baruch Velan, Johannes Löwer, Avigdor Shafferman, Gerd Sutter	2008	47
10	Parsing the role of NSP1 in SARS-CoV-2 infection Cell Reports ·Tal Fisher, Avi Gluck, Krishna Narayanan, Makoto Kuroda, Aharon Nachshon, Jason Hsu, Peter Halfmann, Yfat Yahalom-Ronen, Hadas Tamir, Yaara Finkel, Michal Schwartz, Shay Weiss, Chien‐Te K. Tseng, Tomer Israely, Nir Paran, Yoshihiro Kawaoka, Shinji Makino, Noam Stern-Ginossar	2022	43
11	Clinical and Immune Responses after Revaccination of Israeli Adults with the Lister Strain of Vaccinia Virus The Journal of Infectious Diseases ·Nadav Orr, Moshe Forman, Hadar Marcus, Shlomo Lustig, Nir Paran, Itamar Grotto, Eyal Klement, Yoav Yehezkelli, Guy Robin, Shaul Reuveny, Avigdor Shafferman, Dani Cohen	2004	35
12	Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics Cell Reports ·Adi Nagler, Shelly Kalaora, Chaya Barbolin, Anastasia Gangaev, Steven L. C. Ketelaars, Michal Alon, Joy A. Pai, Gil Benedek, Yfat Yahalom-Ronen, Noam Erez, Polina Greenberg, Gal Yagel, Aviyah Peri, Yishai Levin, Ansuman T. Satpathy, Erez Bar‐Haim, Nir Paran, Pia Kvistborg, Yardena Samuels	2021	35
13	Identification and Whole-Genome Sequencing of a Monkeypox Virus Strain Isolated in Israel Microbiology Resource Announcements ·Inbar Cohen-Gihon, Ofir Israeli, Ohad Shifman, Noam Erez, Sharon Melamed, Nir Paran, Adi Beth-Din, Anat Zvi	2020	33
14	Challenges and Achievements in Prevention and Treatment of Smallpox Vaccines ·Sharon Melamed, Tomer Israely, Nir Paran	2018	32
15	Cellular DNA Ligase I Is Recruited to Cytoplasmic Vaccinia Virus Factories and Masks the Role of the Vaccinia Ligase in Viral DNA Replication Cell Host & Microbe ·Nir Paran, Frank S. De Silva, Tatiana G. Senkevich, Bernard Moss	2009	29
16	Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2 Nature Communications ·Ma’ayan Israeli, Yaara Finkel, Yfat Yahalom-Ronen, Nir Paran, Theodor Chitlaru, Ofir Israeli, Inbar Cohen-Gihon, Moshe Aftalion, Reut Falach, Shahar Rotem, Uri Elia, Ital Nemet, Limor Kliker, Michal Mandelboim, Adi Beth-Din, Tomer Israely, Ofer Cohen, Noam Stern‐Ginossar, Adi Bercovich-Kinori	2022	29
17	Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response Vaccine ·Shlomo Lustig, Galia Maik-Rachline, Nir Paran, Sharon Melamed, Tomer Israely, Noam Erez, Nadav Orr, Shaul Reuveny, Arie Ordentlich, Orgad Laub, Avigdor Shafferman, Baruch Velan	2009	29
18	Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus Journal of Biological Chemistry ·Einat B. Vitner, Hagit Achdout, Roy Avraham, Boaz Politi, Lilach Cherry, Hadas Tamir, Yfat Yahalom-Ronen, Nir Paran, Sharon Melamed, Noam Erez, Tomer Israely	2021	29
19	Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response Virology Journal ·Nir Paran, Shlomo Lustig, Anat Zvi, Noam Erez, Tomer Israely, Sharon Melamed, Boaz Politi, D. Ben‐Nathan, Paula A. Schneider, Bat‐El Lachmi, Ofir Israeli, Dana Stein, Reuven Levin, Udy Olshevsky	2013	27
20	The earliest steps in hepatitis B virus infection Biochimica et Biophysica Acta (BBA) - Biomembranes ·Arik Cooper, Nir Paran, Yosef Shaul	2003	26

About Nir Paran

Nir Paran is a scholar working on Virology, Infectious Diseases, Epidemiology, Immunology and Hepatology, having authored 58 papers that have together received 2.0k indexed citations. Recurring topics across this work include Poxvirus research and outbreaks (24 papers), SARS-CoV-2 and COVID-19 Research (17 papers), Herpesvirus Infections and Treatments (14 papers), Bacillus and Francisella bacterial research (9 papers), Bacteriophages and microbial interactions (7 papers), Immunotherapy and Immune Responses (7 papers), Hepatitis B Virus Studies (6 papers) and COVID-19 Clinical Research Studies (6 papers). The work is most often cited by research in Virology (659 citations), Infectious Diseases (772 citations), Epidemiology (768 citations), Hepatology (117 citations) and Immunology (308 citations). Nir Paran has collaborated with scholars based in Israel, United States and Japan. Frequent co-authors include Sharon Melamed, Tomer Israely, Hadas Tamir, Yfat Yahalom-Ronen, Ofir Israeli, Hagit Achdout, Shay Weiss, Yosef Shaul, Noam Erez and Adi Beth-Din. Their work appears in journals such as Viruses, The Journal of Infectious Diseases, Scientific Reports, Vaccine and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact